Danazol therapy in autoimmune hemolytic anemia associated with systemic lupus erythematosus.
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
Danazol successfully treated severe autoimmune hemolytic anemia in a patient with systemic lupus erythematosus who failed other therapies, indicating its potential as a therapeutic option for this condition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
We describe a patient with systemic lupus erythematosus (SLE) complicated by severe autoimmune hemolytic anemia. Therapy with corticosteroids, splenectomy, azathioprine, chlorambucil, and intravenous immunoglobulin was unsuccessful. She responded to danazol, however, with maintenance of her hemoglobin and reductions in her transfusion and corticosteroid requirement. Thus, danazol may represent an important therapeutic option in the treatment of autoimmune hemolytic anemia.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
SciLite annotations
chemicals 7
danazol
corticosteroid
azathioprine
chlorambucil
danazol
corticosteroid
danazol
Source provenance
- openalex
- last seen: 2026-05-10T10:28:17.326268+00:00
- scilite
- last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0
· commercial use OK